Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund stage 3 cell therapy trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submission (PDF) for an...

Frazier Life Sciences collects $630M for little, mid-cap biotechs

.Frazier Life Sciences has actually sourced a better $630 thousand for its own fund focused on small...

GigaGen achieves up to $135M BARDA dollars to beat botox

.Antibody fan GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its own tec...

GPCR firm Septerna files for IPO on strength of preclinical data

.Septerna is about to learn how a biotech without "any sort of meaningful clinical information" meal...

Kurma shuts first $154M haul for largest biotech fund yet

.European VC organization Kurma Allies has actually revealed its most up-to-date biotech fund, with ...

Prothena promotes one officer while one more leaves behind-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shooting...

Editas profit Vertex Cas9 licensing liberties for $57M

.Versus the background of a Cas9 license struggle that rejects to pass away, Editas Medicine is actu...

Ultragenyx fine-tunes gene treatment dosing to call up efficacy

.A minority of individuals taking Ultragenyx Drug's Wilson condition gene therapy UX701 have actuall...

Biopharma unemployment price stabilizes in Q3: Ferocious Biotech evaluation

.As summertime heat energy looks to cool down winds, really hopes that this year will carry wide-spr...

J &amp J drops phase 2 dengue prospect in newest switch coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own transmittable health condition pipe has actually...